LABORATORY RESEARCH USE ONLY β This compound is NOT for human consumption, veterinary use, or therapeutic applications.
Nootropic PeptidesNeurological Research㪠RUO
PE-22-28
Molecular Data
Formula
C35H53N9O11
Mol. Weight
800.00 Da
CAS Number
N/A
Purity
β₯95% (HPLC)
Appearance
White lyophilized powder
Storage
-20Β°C, desiccated
Research Overview
PE-22-28 is a synthetic peptide fragment derived from the spadin analog of sortilin, targeting TREK-1 potassium channels.
Mechanism of Action
Blocks TREK-1 (TWIK-related potassium channel-1), enhancing serotonergic and noradrenergic neurotransmission in the central nervous system.
Research Applications
TREK-1 channel pharmacology, antidepressant mechanism research, serotonergic pathway studies, neuroplasticity investigation, rapid-onset anxiolytic modeling.
Key Research Findings
TREK-1 blockade produces antidepressant-like effects within days rather than weeks in rodent models. Enhanced hippocampal neurogenesis.
MANDATORY DISCLAIMER: PE-22-28 as referenced on this page is strictly for in-vitro laboratory research and forensic applications only. It is NOT for human consumption, veterinary use, diagnostic purposes, therapeutic applications, or any form of bodily introduction. Any reference to research outcomes pertains exclusively to controlled laboratory settings. Researchers must comply with all applicable local, state, and federal regulations.
